blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2272536

EP2272536 - Hot-melt extrudable Pharmaceutical formulation [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.03.2017
Database last updated on 21.03.2026
Most recent event   Tooltip06.07.2018Lapse of the patent in a contracting state
New state(s): LU		published on 08.08.2018  [2018/32]
Applicant(s)For all designated states
Board of Regents, The University of Texas System
201 West 7th Street
Austin, TX 78712 / US
[2016/18]
Former [2011/02]For all designated states
Board of Regents, The University of Texas System
201 West 7th Street
Austin, TX 78712 / US
Inventor(s)01 / McGinity, James
4209 Dunning Lane
Austin, TX 78746 / US
02 / Zhang, Feng
1341 David Street
Suite 3-404
San Mateo
CA 94403 / US
 [2016/18]
Former [2011/26]01 / McGinity, James
4209 Dunning Lane
Austin, TX 78746 / US
02 / Zhang, Feng
1341 David Street Suite 3-404 San Mateo
CA 94403 / US
Former [2011/02]01 / McGinity, James
4209 Dunning Lane
Austin, TX 78746 / US
02 / Zhang, Feng
405 31st East Street
Austin, TX 78712 / US
Representative(s)Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
[N/P]
Former [2016/18]Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Former [2014/10]Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham, NG1 5GG / GB
Former [2011/02]Zvesper, Thomas
Mathys & Squire LLP 120 Holborn
London EC1N 2SQ / GB
Application number, filing date10185104.624.06.1997
[2011/02]
Priority number, dateUS19960020623P26.06.1996         Original published format: US 20623 P
[2011/02]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2272536
Date:12.01.2011
Language:EN
[2011/02]
Type: A3 Search report 
No.:EP2272536
Date:16.05.2012
Language:EN
[2012/20]
Type: B1 Patent specification 
No.:EP2272536
Date:04.05.2016
Language:EN
[2016/18]
Search report(s)(Supplementary) European search report - dispatched on:EP17.04.2012
ClassificationIPC:A61K47/34, A61K9/20
[2011/02]
CPC:
A61K9/2031 (EP,US); A61K9/2095 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2016/18]
Former [2011/02]AT,  BE,  CH,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
TitleGerman:Extrudierbare pharmazeutische Schmelzklebstoffformulierung[2011/02]
English:Hot-melt extrudable Pharmaceutical formulation[2011/02]
French:Formulation pharmaceutique extrudable thermofusible[2011/02]
Examination procedure12.11.2012Amendment by applicant (claims and/or description)
12.11.2012Examination requested  [2012/51]
24.06.2013Despatch of a communication from the examining division (Time limit: M06)
27.01.2014Reply to a communication from the examining division
29.10.2015Cancellation of oral proceeding that was planned for 01.12.2015
16.11.2015Communication of intention to grant the patent
01.12.2015Date of oral proceedings (cancelled)
15.03.2016Fee for grant paid
15.03.2016Fee for publishing/printing paid
15.03.2016Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP09003265.7  / EP2065055
EP97931455.6  / EP1014941
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19970931455) is  19.04.2006
Opposition(s)07.02.2017No opposition filed within time limit [2017/15]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
27.01.2014Request for further processing filed
27.01.2014Full payment received (date of receipt of payment)
Request granted
11.02.2014Decision despatched
Fees paidRenewal fee
22.12.2010Renewal fee patent year 03
22.12.2010Renewal fee patent year 04
22.12.2010Renewal fee patent year 05
22.12.2010Renewal fee patent year 06
22.12.2010Renewal fee patent year 07
22.12.2010Renewal fee patent year 08
22.12.2010Renewal fee patent year 09
22.12.2010Renewal fee patent year 10
22.12.2010Renewal fee patent year 11
22.12.2010Renewal fee patent year 12
22.12.2010Renewal fee patent year 13
22.12.2010Renewal fee patent year 14
07.06.2011Renewal fee patent year 15
31.03.2012Renewal fee patent year 16
31.03.2013Renewal fee patent year 17
31.03.2014Renewal fee patent year 18
05.06.2015Renewal fee patent year 19
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT04.05.2016
BE04.05.2016
DK04.05.2016
ES04.05.2016
FI04.05.2016
IT04.05.2016
MC04.05.2016
NL04.05.2016
SE04.05.2016
IE24.06.2016
LU24.06.2016
CH30.06.2016
LI30.06.2016
FR04.07.2016
GB04.08.2016
GR05.08.2016
PT05.09.2016
[2018/32]
Former [2017/38]AT04.05.2016
BE04.05.2016
DK04.05.2016
ES04.05.2016
FI04.05.2016
IT04.05.2016
MC04.05.2016
NL04.05.2016
SE04.05.2016
IE24.06.2016
CH30.06.2016
LI30.06.2016
FR04.07.2016
GB04.08.2016
GR05.08.2016
PT05.09.2016
Former [2017/24]AT04.05.2016
BE04.05.2016
DK04.05.2016
ES04.05.2016
FI04.05.2016
IT04.05.2016
MC04.05.2016
NL04.05.2016
SE04.05.2016
IE24.06.2016
CH30.06.2016
LI30.06.2016
FR04.07.2016
GR05.08.2016
PT05.09.2016
Former [2017/22]AT04.05.2016
BE04.05.2016
DK04.05.2016
ES04.05.2016
FI04.05.2016
IT04.05.2016
MC04.05.2016
NL04.05.2016
SE04.05.2016
CH30.06.2016
LI30.06.2016
FR04.07.2016
GR05.08.2016
PT05.09.2016
Former [2017/17]AT04.05.2016
BE04.05.2016
DK04.05.2016
ES04.05.2016
FI04.05.2016
IT04.05.2016
MC04.05.2016
NL04.05.2016
SE04.05.2016
GR05.08.2016
PT05.09.2016
Former [2017/10]BE04.05.2016
DK04.05.2016
ES04.05.2016
FI04.05.2016
IT04.05.2016
NL04.05.2016
SE04.05.2016
GR05.08.2016
PT05.09.2016
Former [2017/07]DK04.05.2016
ES04.05.2016
FI04.05.2016
IT04.05.2016
NL04.05.2016
SE04.05.2016
BE30.06.2016
GR05.08.2016
PT05.09.2016
Former [2017/03]ES04.05.2016
FI04.05.2016
IT04.05.2016
NL04.05.2016
SE04.05.2016
BE30.06.2016
GR05.08.2016
PT05.09.2016
Former [2016/52]ES04.05.2016
FI04.05.2016
NL04.05.2016
SE04.05.2016
GR05.08.2016
PT05.09.2016
Former [2016/51]ES04.05.2016
FI04.05.2016
NL04.05.2016
GR05.08.2016
PT05.09.2016
Former [2016/50]ES04.05.2016
FI04.05.2016
NL04.05.2016
Former [2016/49]FI04.05.2016
NL04.05.2016
Documents cited:Search[XI] US4713243  (SCHIRALDI MICHAEL T et al.)
 [A] EP0008131  (UNION CARBIDE CORP et al.)
 [XA]   A. APICELLA ET AL: "Poly(ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release", BIOMATERIALS, vol. 14, no. 2, 1993, pages 83 - 90, XP002344055

DOI:   http://dx.doi.org/10.1016/0142-9612(93)90215-N
 [T]   MICHAEL M. CROWLEY ET AL: "Stabiity of polyethylene oxide in matrix tablets prepared by hot melt extrusion", BIOMATERIALS, vol. 23, 2002, pages 4241 - 4248, XP002344056

DOI:   http://dx.doi.org/10.1016/S0142-9612(02)00187-4
ExaminationEP0661045
by applicantEP0177893
 EP0598606
 US5004601
 US4806337
 US4774074
 US4774976
 US4629621
   J.M. HARRIS,: "Poly(ethylene glycol) Chemistry: Biotechnical and Biomedical Applications", PLENUM PRESS
   "Remington's Pharmaceutical Sciences", 1985, MACK PUBLISHING COMPANY, pages: 1418
   G. BECHMANN: "Ueber die verzgerte Wirkstoff-Freigabe aus peroralen, festen Arzneiformen", PHD. THESIS, 1964
   EL-EGAKEY ET AL., PHARM. ACTA. HELV., vol. 46, 1971, pages 31 - 52
   HTTENRAUCH ET AL., PHARMACIE, vol. 30, 1975, pages 229 - 233
   RIPPIE ET AL., J: PHARM. SCI., vol. 58, 1969, pages 428 - 431
   SHIVHIVANAND ET AL., PHARM. RES., vol. 8, 1991, pages S-192
   PRAPAITRAKUL ET AL., PHARM. RES., vol. 6, 1989, pages S-98
   MANK ET AL., PHARMAZIE, vol. 44, 1989, pages 773 - 776
   MANK ET AL., PHARMAZIE, vol. 45, 1990, pages 592.593
   FOLLONIER ET AL., DRUG DEVELOP. AND INDUST. PHARM., vol. 2Q, no. 8, 1994, pages 1323 - 1339
   "Remington's Pharmaceutical Sciences, 17th ed.", 1985, MACK PUBLISHING CO., pages: 18042
   GOODMAN; GILMAN'S: "The Pharmacological Basis of Therapeutics, 7th ed.", 1985, MACMILLAN PUBLISHING CO.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.